Sanguine's mission is to accelerate translational biomedical research by removing the barriers to patient participation. We partner with leading pharmaceutical and emerging biotech companies to provide researchers with an enhanced ability to recruit study participants and collect clinically relevant biospecimens and leukopaks through our mobile phlebotomy workforce and apheresis site network across the United States. Our direct-to-patient model removes barriers to participation and has already energized a homegrown community of more than 70,000 patient members to get involved with accelerating research for the conditions they battle with. By empowering patients to participate from the comfort of their homes or local sites, together with our more than 100 advocacy group partnerships and highly strategic online recruitment campaigns, we ensure that researchers who partner with us touch even the hardest-to-reach populations.
Sanguine's Fully Integrated Service Solutions include:
- Healthy & Diseased-State Leukopak Collection
- LeukoLots™
- Patient-powered Mobile Biospecimen Collection
- Patient Data
- Employer Onsite Collection Programs
- Biorepository Services
